Helping emerging biopharma compete like the big players — without the big infrastructure.

For lean clinical teams, every manual handoff costs time you don't have. Protocol changes trigger cascades of rework across your EDC, your submission documents, your site materials. Your data scientists and clinical ops are re-entering the same information into different systems — over and over.

There's a better way. The foundation, the Unified Study Definition Model (USDM), is a machine-readable standard that lets your study design flow automatically across every system in your trial. Write once. Update once. Everything stays in sync.

Imagine if you could automatically generate…

❖ Regulatory submission documents (ICH M11 compliant)

❖ Site and patient-facing materials

❖ EDC and CRF configuration

❖ SDTM Trial datasets and Define.xml

This is Digital Data Flow, and it's how the industry is leveling up.

AdoptDigitalData helps you lean in.

Lean biotech companies don't need to build complex software infrastructure to benefit from a digital data flow; they just need to know how to govern it with their CRO. Mid-market pharma organizations may want their internal teams to transition to a modern, structured data workflow. Regardless of your starting point, AdoptDigitalData helps you progress on your digital data flow journey. We focus entirely on mindset and methods, acting as your client-side data advocate.

Ready to protect your clinical assets and modernize your vendor oversight? Reach out for a free consultation.